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Abstract
Facial asymmetry is found in patients with or without cosmetic facial alterations. Some patients have facial
asymmetry that manifests underlying skeletal problems, while others have only limited soft-tissue facial asymmetry.
Orthognathic surgery brings about a dermatic change, as soft tissue covers underlying bones. Limited soft-tissue
asymmetry, meanwhile, is difficult to correct. The treatment modalities for the creation or restoration of an
esthetically pleasing appearance were autogenous fat grafts, cartilage graft, and silicon injections.
A young female patient had right-side facial asymmetry. The clinical assessment involved visual inspection of the
face and palpation to differentiate soft tissue and bone. Although the extra-oral examination found facial
asymmetry with skin atrophy, the radiographic findings revealed no mandibular atrophy or deviation. She was
diagnosed as localized scleroderma with muscle spasm.
In conclusion, facial asymmetry patients with skeletal asymmetry can be esthetically satisfied by orthognathic
surgery; however, facial atrophy patients with skin or subdermal tissue contraction need treatment by cosmetic
dermatological surgery and orthodontic correction.
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Background
As patients become more aware of and concerned
about facial esthetics, so too, they grow more self-
conscious about facial asymmetry and more desirous of
correcting it. Although most faces show some degree of
mild facial asymmetry, not all cases require surgical
correction. Facial asymmetry is found in patients with
or without cosmetic facial alterations. Some patients
have facial asymmetry that manifests underlying skel-
etal problems, while others have only limited soft-tissue
facial asymmetry. Resolution of facial asymmetry, in
any case, is becoming an important goal of orthodontic
treatment and orthognathic surgery.
Facial asymmetry prevalence rates range between 21
and 85 % [1]. The etiology of facial asymmetry among
diverse patients is still unknown, and indeed, its causes
are multivariate. Bishara SE et al. reported on the many
and various etiologic factors that are implicated in
genetic or congenital deformities (cleft lip and palate,
condyle hypoplasia, hemifacial microsomia, etc.), de-
velopmental asymmetry (arising during growth), and
acquired, environmental asymmetry (habits, disease,
trauma, etc.) [2]. Limited soft-tissue facial asymmetry,
otherwise known as skeletal facial asymmetry, is rare.
Its differential diagnosis includes post-traumatic scarring,
facial atrophy known as Parry-Romberg syndrome (PRS),
and linear scleroderma [3].
Patients with facial asymmetry have not only problems
of facial skeletal deformity but also esthetic and morpho-
logic problems related to skin atrophy. To obtain the
best resolution, patient diagnosis, treatment planning,
and result assessment should be based on accurate skel-
etal as well as morphological analysis and measurement.
To those ends, three-dimensional models, traditional
radiologic procedures, and soft-tissue examination are
employed.
In cases of soft-tissue facial asymmetry without skeletal
deformities, some pathological conditions are found. In
1891, C. J. Nixon reported on localized scleroderma
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(LS) patients with the rare clinical feature hemiatrophia
facialis [4]. This is characterized by thickening of the
skin and underlying tissues by abnormally increased
collagen deposition resulting in hardened lesions. PRS,
a rare type of LS, is characterized by facial atrophy
affecting the soft tissue and muscles as well as adjacent
structures. PRS is categorized as mild, moderate, or
severe on the basis of bone involvement in the region
of the trigeminal nerve. The prevalence rate of PRS in
general population is estimated to be at least 1 per
700,000 [5].
Soft-tissue facial asymmetry is rarely reported in the
field of oral and maxillofacial surgery (OMS) group.
Herein then, the case of a 27-year-old female patient
with facial asymmetry and LS diagnosis is presented.
We proposed that soft and hard tissue analyses for fa-
cial asymmetry were needed to allow effective, accurate,
and beneficial treatment.
Case presentation
A young female patient, aged 27 years, visited the hospital
on November 18, 2009 complaining of facial asymmetry
with right temporomandibular joint (TMJ) pain and noise,
spasm of the right masseter muscle (MA), and trismus.
Her mouth-opening range between the upper and lower
incisors was 34 mm. Based on an analysis of the magnetic
resonance imaging (MRI) findings, anterior disk displace-
ment with reduction was diagnosed.
The patient also had right-side facial asymmetry. On
June 9, 2010, she was evaluated by clinical examination,
Fig. 1 a Before orthodontic treatment. Intraoral photos were taken on 2 July 2010. b After orthodontic treatment. Intraoral photos were taken on
1 December 2012. c Follow-up check. Intraoral photos were taken on 13 December 2014
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dental casts, and radiography. The clinical assessment
involved visual inspection of the face and palpation to dif-
ferentiate soft tissue and bone. Although the extra-oral
examination found facial asymmetry with skin atrophy, the
radiographic findings revealed no mandibular atrophy or
deviation. The universal treatment plan entails the repair
of bone defects via orthognathic surgery, though correction
of limited soft-tissue facial asymmetry by this route is prob-
lematic. Therefore, we planned, for creation of an esthetic-
ally pleasing appearance, not orthognathic surgery but
orthodontic treatment to level and align the dentition. Be-
cause she was afraid of the major surgery like orthognathic
surgery. And we recommended, for correction of her facial
asymmetry, if she so desired, autologous fat transplant-
ation. The occlusion of the dentition was completed ortho-
dontic treatment between November 2010 and December
2012 (Fig. 1a–c).
The patient had no history of medical problems, trauma,
and neurologic symptoms. During the clinical examin-
ation, we could not find any abnormal findings other than
skin atrophy. Radiographically, atrophic soft tissue of the
right chin and compensatory bone formation on the right
mandible angle were observed (Fig. 2a–c). The general
examination results, which included a complete blood cell
count, serum chemistry, liver function tests, and chest
radiography, were within the normal limits. Anti-nuclear
antibody (ANA), anti-scl 70 antibody, anti-centromere B
antibody, anti-ds DNA antibody, and rheumatoid factor
(RF) tests also were all within normal ranges.
And we decided to reduce TMJ pain. The patient was
treated for TMJ disorder (TMD) with occlusal stabilization
appliance as well as arthrocentesis and lavage. Unilateral
muscle spasm and trismus, additionally, were resolved by
trigger point injection (TPI, 7:3 = dexamethasone disodium
phosphate/lidocaine hydrochloride) and botulinum toxin
therapy (Botox) of the right MA. After 5 months of treat-
ment, she had no residual pain and boasted a painless TMJ
range of motion and maximal 50 mm mouth-opening
range. However, spasm of the right MA was observed once
per week.
As muscle strain and spasm arose more frequently, we
consulted the Rheumatoid Internal Medicine (RI) and
Fig. 2 Radiographies were taken on a 2 July 2010, b 1 December 2012, and c 13 December 2014
Kim et al. Maxillofacial Plastic and Reconstructive Surgery  (2015) 37:29 Page 3 of 7
Neurology (NU) departments for additional evaluation
of the clinical findings, laboratory examination results,
and radiographic imaging. On March 4, 2014, the pa-
tient was diagnosed, in RI, as LS with muscle spasm. At
that time, she was treated by anti-gout and anti-
inflammatory drugs and muscle relaxants. The adminis-
tered therapeutic doses of medication were colchicine
0.6 mg/two times per day (b.i.d.), and eperisone 50 mg/
b.i.d. for 4 months. The area of skin atrophy was softer
in texture than before. Nevertheless, the patient often
reported sudden onset of spasms of the right MA.
Subsequently, she opted to discontinue treatment at RI
and NU.
Follow-up was carried out for 3 years, revealing good
dentition; unfortunately, the patient’s soft-tissue facial
asymmetry remained (Fig. 3a–c).
Discussion
Facial asymmetry has dental, skeletal, and soft-tissue com-
ponents. Its management entails a combination of ortho-
dontic treatment and orthognathic surgery for bone
deformities. Orthognathic surgery, however, is challenging,
Fig. 3 a Before orthodontic treatment. Extra-oral photos were taken on 2 July 2010. b After orthodontic treatment. Extra-oral photos were taken
on 1 December 2012. c Follow-up check. Extra-oral photos were taken on 13 December 2014
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in that facial asymmetry treatment affects three-dimensional
hard and soft tissue. Orthognathic surgery brings about a
dermatic change, as soft tissue covers underlying bones.
Limited soft-tissue asymmetry, meanwhile, is difficult to
correct. The treatment modalities for the creation or
restoration of an esthetically pleasing appearance were au-
togenous fat grafts, cartilage graft, and silicon injections.
LS has very diverse etiologies, and its pathogenetic
mechanism is still unclear. It is an autoimmune disease
characterized by cutaneous disorder and caused by in-
creased collagen density resulting from a complex inter-
play of immune, genetic, extracellular matrix (ECM)
disorder, and inflammation. Connective tissue disorders
of the skin also show the characteristic activation of fi-
brosis resulting in excessive production and accumula-
tion of collagen fibers. In its pathogenic features, LS has
two main clinical categories that are recognized: sys-
temic sclerosis (SSc), characterized by variable visceral
involvement (mainly the esophagus, lung, and vascular
system), and LS, which does not involve internal organs
but is benign and self-limited (i.e., confined to the skin
and/or subcutaneous tissues).
The common clinical signs of LS are linear sclero-
derma, plaque scleroderma, and generalized sclero-
derma. Cases of PRS, characterized by progressive
hemiatrophy of the face and guttate scleroderma, are
relatively infrequent.
Although the clinical aspects of scleroderma manifest
at all ages, the peak age of incidence is the second dec-
ade of life [6]. LS more often occurs in women than in
men, at a ratio of 3~4:1 [7]. Cho HK and Chun SI found
that most patients are between 11 and 30 years of age
and that women are affected more than men [6]. Kwon
OS et al. reported a female-to-male ratio of 3.3:1 for
morphea and of 4.1:1 for LS among those under age 30
[8]. Scrivener Y et al. concluded that 4 (7 %) of the 62
patients with LS shared clinical features on the cheek
and/or mentum [9].
LS affects a variety of areas including the skin and adi-
pose tissue as well as, sometimes, the fascia, muscles
and bones [10]. Depending on the fibrotic action, which
mainly affects the deeper layers of the connective tissue,
LS rarely leads to esthetic problems, extremities atrophy,
flexion contractures, and disability [11].
LS is differentiated from the systemic form of the dis-
ease, sclerosis, the Raynaud phenomenon (i.e., internal
organ involvement). Diagnosis of LS, with respect at
least to the proper identification of its distinct features,
can be difficult. In 1995, Peterson LS et al. proposed an
LS classificatory scheme that has since been adopted
with few modifications by the majority of reviews
published since that time (see Table 1) [12]. It groups LS
into five subtypes: plaque morphea, generalized mor-
phea, bullous morphea, linear morphea, and deep
morphea. LS is diagnosed whenever a combination of
two or more of these subtypes is present. In 2004,
Pediatric Rheumatology European Society published a
newly proposed LS classification scheme to correct that
earlier put forward by Peterson et al.: circumscribed
morphea, linear scleroderma, generalized morphea, pan-
sclerotic morphea, and mixed morphea (see Table 2)
[13]. In 2009, Kreuter A et al. suggested a subtype classi-
fication that considers the extent and depth of fibrosis
and includes, correspondingly, the following four cat-
egories: the limited type, the generalized type, the linear
type, and the deep type (see Table 3) [10].
PRS is a rare disorder characterized by slow and pro-
gressive hemiatrophy of the soft tissue of the face,
muscle, and bone. The etiologies of PRS are not well
understood but are thought to include trauma, infection,
and auto-immunity [14]. This syndrome involves derma-
tomes or multiple branches of the trigeminal nerve. It
manifests as progressive shrinking and deformation of
one side of the face, thus resulting in unilateral facial
atrophy. The deformity effected by PRS is an issue
not only of esthetics but also of facial functionality.
PRS in fact has been linked with neurologic,
Table 1 Classification of morphea or localized scleroderma
Plaque morphea Plaque morphea
Guttate morphea
Atrophoderma of Pasini and Pierini
Keloid morphea (nodular morphea)
(Lichen sclerosus et atrophicus)
Generalized morphea
Bullous morphea
Linear morphea Linear morphea (linear scleroderma)
Morphea en coup de sabre
Progressive facial hemiatrophy
Deep morphea Morphea profunda
Subcutaneous morphea
Eosinophilic fasciitis
Pansclerotic morphea of childhood
Source: Peterson LS et al., 1995 [12]
Table 2 Classification of morphea or localizes scleroderma
Circumscribed morphea a) Superficial
1. Deep





Source: Consensus Conference, Padua (Italy), 2004 [13]
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ophthalmologic, rheumatologic, maxillofacial, and
orthodontic issues [15].
Although PRS is often associated with linear sclero-
derma, differentiating it is very challenging. Moreover,
either clinical symptom can slowly overlap with or transi-
tion into the other. There are no clear criteria universally
agreed upon to differentiate PRS from linear scleroderma
[16]; the clinical and laboratory features of both diseases
have been found to coexist in many patients. However, the
commonly reported neurologic manifestations of PRS are
seizures and headaches [17].
Our patient did not show any neurologic lesion, though
she did show clear features of facial asymmetry. Therefore,
we diagnosed LS with right facial atrophy.
Although no effective global treatment for LS exists, a
variety of therapeutic management modalities are avail-
able, among which are topical medications, immunosup-
pressive pharmacological agents, physical therapy, and
phototherapy. The medication options include cortico-
steroids, methotrexate, calcipotriol, D-penicillamine,
interferon-gamma, imiquimod, and tacrolimus. Unfortu-
nately however, for some LS types, such treatment is of
only limited effectiveness, and for some other LS types,
symptoms worsen, or the risk of relapse is even higher,
when so treated. The first case of successful ultraviolet
radiation (UV) phototherapy for LS was reported in
1994. Since then, the literature on the entire spectrum
of the anti-fibrotic and anti-inflammatory effects of psor-
alen plus UVA (PUVA), UVA-1, and topical photo-
dynamic therapy has rapidly expanded [18]. In 2006,
Lim SH et al. reported that low-dose UVA-1 was the
phototherapy with the greatest efficacy and safety for LS
patients [17].
There are many surgical-reconstructive techniques used
in cases where there is loss of volume to the face or other
area. Balaji SM proposed gluteal- and abdominal-fat graft-
ing for PRS, by which, after the graft is harvested from the
area near the inguinal crease, its tags are inserted into the
atrophic lesion [19]. Zanelato TP et al., similarly, reported
the implantation of autologous fat globules for PRS [20].
Therefore, we report the rare case of a facial asym-
metry patient diagnosed as LS with soft-tissue atrophy.
Clinically, our goal was to report on this soft-tissue facial
asymmetry patient and to carefully diagnose, both prepa-
ratorily for surgery and to reduce diagnostic mistakes.
Conclusions
In conclusion, oral and maxillofacial surgeons require,
following their analysis of facial asymmetry patients, a
treatment plan. It is important in this regard to dif-
ferentiate limited soft-tissue facial asymmetry (without
bone deformities) and bone-facial asymmetry. Facial
asymmetry patients with skeletal asymmetry can be
esthetically satisfied by orthognathic surgery; however,
facial atrophy patients with skin or subdermal tissue
contraction need, as in the present case, treatment by
cosmetic dermatological surgery and orthodontic cor-
rection. We propose therefore the highlighting of this
rare case in order to improve awareness and, espe-
cially, knowledge.
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